These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells. Congleton J; MacDonald R; Yen A Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854 [TBL] [Abstract][Full Text] [Related]
4. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor. Rashid A; Duan X; Gao F; Yang M; Yen A Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659 [TBL] [Abstract][Full Text] [Related]
5. 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells. Bunaciu RP; Yen A Mol Cancer; 2013 May; 12():39. PubMed ID: 23656719 [TBL] [Abstract][Full Text] [Related]
6. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells. Bunaciu RP; Jensen HA; MacDonald RJ; LaTocha DH; Varner JD; Yen A PLoS One; 2015; 10(8):e0135668. PubMed ID: 26287494 [TBL] [Abstract][Full Text] [Related]
7. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK. Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117 [TBL] [Abstract][Full Text] [Related]
8. Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells. MacDonald RJ; Bunaciu RP; Ip V; Dai D; Tran D; Varner JD; Yen A Leuk Lymphoma; 2018 Dec; 59(12):2941-2951. PubMed ID: 29569971 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity. Congleton J; Shen M; MacDonald R; Malavasi F; Yen A Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085 [TBL] [Abstract][Full Text] [Related]
10. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation. Rashid A; Wang R; Zhang L; Yue J; Yang M; Yen A Exp Cell Res; 2020 Sep; 394(1):111989. PubMed ID: 32283065 [TBL] [Abstract][Full Text] [Related]
11. Activation of the aryl hydrocarbon receptor AhR Promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4. Bunaciu RP; Yen A Cancer Res; 2011 Mar; 71(6):2371-80. PubMed ID: 21262915 [TBL] [Abstract][Full Text] [Related]
12. Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells. Hong HY; Varvayanis S; Yen A Differentiation; 2001 Aug; 68(1):55-66. PubMed ID: 11683493 [TBL] [Abstract][Full Text] [Related]
13. The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via RAF-1 independent activation of MEK/ERK. Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Cai X Food Chem Toxicol; 2019 Apr; 126():303-312. PubMed ID: 30840849 [TBL] [Abstract][Full Text] [Related]
14. Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts. Jensen HA; Bunaciu RP; Ibabao CN; Myers R; Varner JD; Yen A PLoS One; 2014; 9(6):e98929. PubMed ID: 24922062 [TBL] [Abstract][Full Text] [Related]
15. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML. Bunaciu RP; MacDonald RJ; Jensen HA; Gao F; Wang X; Johnson L; Varner JD; Yen A Leuk Lymphoma; 2019 Jul; 60(7):1697-1708. PubMed ID: 30570341 [TBL] [Abstract][Full Text] [Related]
17. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is. Yen A; Varvayanis S In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):249-55. PubMed ID: 10852350 [TBL] [Abstract][Full Text] [Related]
18. The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. Chin PC; Liu L; Morrison BE; Siddiq A; Ratan RR; Bottiglieri T; D'Mello SR J Neurochem; 2004 Aug; 90(3):595-608. PubMed ID: 15255937 [TBL] [Abstract][Full Text] [Related]
19. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells. Kazim N; Yen A Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491 [TBL] [Abstract][Full Text] [Related]
20. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2. Lee M Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]